Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
FDA Approves Higher Dose Naloxone, Kloxxado
Naloxone has been known by different brand names over the years as the primary treatment of opioid overdose.
Workers' Comp
News Release
Mitchell | Genex | Coventry Signs Agreement to Acquire QualCare Alliance Networks Inc.
Deal will strengthen company's network in New Jersey
Workers' Comp
News Release
Risk & Insurance: How Bayne, Genex and Sikorsky Banded Together to Create an Optimal Return-to-Work Program
In this National Comp session, Sikorsky, a Lockheed Martin Company, shares their newly created program that significantly decreased an injure
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
Podcast